Search engine for other government resources

Exemestane - National Cancer Institute

Exemestane is approved to treat: Breast cancer that is advanced. Breast cancer that is early stage and estrogen receptor positive. Exemestane is used ...
www.cancer.gov/about-cancer/treatment/drugs/exemestane

Exemestane MedlinePlus Drug Information

Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods) and who ...
medlineplus.gov/druginfo/meds/a607006.html

Exemestane C20H24O2 - PubChem

Exemestane is an irreversible steroidal aromatase inhibitor, with antiestrogen and antineoplastic activities. Upon oral administration, exemestane ...
pubchem.ncbi.nlm.nih.gov/compound/exemestane

Exemestane Reduces Breast Cancer Risk in High-Risk ...

"The good news is that exemestane has a completely different toxicity profile," said Susan Domchek, M.D., director of the Cancer Risk Evaluation ...
www.cancer.gov/types/breast/research/exemestane-reduces-risk

Exemestane in the prevention setting

Exemestane is a well-tolerated and effective therapy for both early and advanced breast cancer. The MAP.3 trial shows at 35 months median follow up, e ...
www.ncbi.nlm.nih.gov/pmc/articles/PMC3349074/

Exemestane a review of its use in postmenopausal women ...

Abstract. Exemestane is an orally active irreversible steroidal aromatase inactivator that effectively suppresses in vivo aromatase activity and ...
pubmed.ncbi.nlm.nih.gov/10882163/

Efficacy Safety Evaluation of Enobosarm in Combo With ...

The patient may receive exemestane with or without everolimus. The primary efficacy endpoint of the study will be the median rPFS. Subjects will ...
clinicaltrials.gov/ct2/show/NCT05065411

PDF AROMASIN exemestane tablets DESCRIPTION AROMASIN H O

AROMASIN (exemestane tablets) S-006 Approved Labeling NDA 20-753/S-006 EBC Indication October 4, 2005 2 Exemestane is an irreversible, steroidal ...
www.accessdata.fda.gov/drugsatfda_docs/label/2005/020753s006lbl.pdf

PDF AROMASIN exemestane Tablets DESCRIPTION

exemestane in fasted healthy postmenopausal women (mean age 55 years). Race: The influence of race on exemestane pharmacokinetics has not been ...
www.accessdata.fda.gov/drugsatfda_docs/label/1999/20753LBL.PDF

PDF Reference ID 2923046

in those receiving exemestane than either tamoxifen or placebo. Treatment-emergent bilirubin elevations (any CTC grade) occurred in 5.3% of exemestane ...
www.accessdata.fda.gov/drugsatfda_docs/label/2011/020753s009s011s012lbl.pdf

Endocrine and clinical endpoints of exemestane as ...

A series of in vitro and in vivo studies have been performed to establish the endocrine and clinical endpoints of the type I anti-aromatase agent exem ...
pubmed.ncbi.nlm.nih.gov/11965226/

Exemestane MedlinePlus medicinas

Exemestane se usa para tratar el cncer de seno en etapas tempranas en las mujeres que han experimentado la menopausia ('cambio de vida'; final de los ...
medlineplus.gov/spanish/druginfo/meds/a607006-es.html

DailyMed - EXEMESTANE tablet film coated

Exemestane tablets are an aromatase inhibitor indicated for: adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3573e3c9-ca05-413f-909f-93607a2ccb79

PDF HIGHLIGHTS OF PRESCRIBING INFORMATION ...

common in those receiving exemestane than either tamoxifen or placebo. -emergent bilirubin elevations Treatment (any CTC grade) occurred in 5.3% of ex ...
www.accessdata.fda.gov/drugsatfda_docs/label/2018/020753s020lbl.pdf

The minimal effective exemestane dose for endocrine ...

Phase I studies have demonstrated that exemestane, an irreversible oral aromatase inhibitor, is able to suppress circulating oestrogen levels. In our ...
pubmed.ncbi.nlm.nih.gov/9274439/

Combination Therapy Shows Promise for Treating Advanced ...

Exemestane, an aromatase inhibitor, is used to treat metastatic breast cancer. For postmenopausal patients with hormone receptor-positive metastatic ...
www.cancer.gov/types/breast/research/everolimus-plus-exemestane

The effect of exemestane on serum lipid profile in ...

Overall, exemestane has no detrimental effect on cholesterol levels and the atherogenic indices, which are well-known risk factors for coronary artery ...
pubmed.ncbi.nlm.nih.gov/14760111/

DailyMed - AROMASIN- exemestane tablet

Exemestane showed no effects on ovarian function, mating behavior, and conception rate in rats given doses up to 20 mg/kg/day (approximately 8 times ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3

DailyMed - EXEMESTANE tablet

Exemestane is an aromatase inhibitor indicated for: adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who ...
dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abde1ccd-0ec9-40d4-b205-fbc00f5878b9

West-Ward Pharmaceuticals Corp EXEMESTANE- exemestane ...

Exemestane is indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to ...
dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=2ecdb646-4d0f-4d1b-ac6a-9cb5deb9ac0d&name=2ecdb646-4d0f-4d1b-ac6a-9cb5deb9ac0d